ALK and non-small cell lung carcinoma: One study comparing a CNS-penetrant TKI alone to a CNS-penetrant TKI with CNS radiation therapy (RT) in EGFR- and ALK-mutated NSCLC found no significant differences in the time to progression or time to intracranial progression between the TKI alone or with CNS RT [143].